These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21207016)

  • 21. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic characteristics of glucose intolerance: the critical role of obesity.
    Sainaghi PP; Castello L; Bergamasco L; Carnevale Schianca GP; Bartoli E
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):86-93. PubMed ID: 17972239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism.
    Kumar S; Olukoga AO; Gordon C; Mawer EB; France M; Hosker JP; Davies M; Boulton AJ
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):47-53. PubMed ID: 8306480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of baseline intact parathyroid hormone levels on severity of primary hyperparathyroidism and outcomes in patients undergoing surgery.
    Kandil E; Alabbas H; Tufaro AP; Carson KA; Tufano RP
    Arch Otolaryngol Head Neck Surg; 2010 Feb; 136(2):147-50. PubMed ID: 20157060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-cell function and insulin sensitivity contribute to the shape of plasma glucose curve during an oral glucose tolerance test in non-diabetic individuals.
    Kanauchi M; Kimura K; Kanauchi K; Saito Y
    Int J Clin Pract; 2005 Apr; 59(4):427-32. PubMed ID: 15853859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D status, physical performance and body mass in patients surgically cured for primary hyperparathyroidism compared with healthy controls - a cross-sectional study.
    Amstrup AK; Rejnmark L; Vestergaard P; Sikjaer T; Rolighed L; Heickendorff L; Mosekilde L
    Clin Endocrinol (Oxf); 2011 Jan; 74(1):130-6. PubMed ID: 21044111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients with normocalcemic primary hyperparathyroidism may have similar metabolic profile as hypercalcemic patients.
    Yener Ozturk F; Erol S; Canat MM; Karatas S; Kuzu I; Dogan Cakir S; Altuntas Y
    Endocr J; 2016; 63(2):111-8. PubMed ID: 26581584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum concentrations of osteocalcin, procollagen type 1 N-terminal propeptide and beta-CrossLaps in obese subjects with varying degrees of glucose tolerance.
    Iglesias P; Arrieta F; Piñera M; Botella-Carretero JI; Balsa JA; Zamarrón I; Menacho M; Díez JJ; Muñoz T; Vázquez C
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):184-8. PubMed ID: 21521304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteocalcin and glucose metabolism in postmenopausal women subjected to aerobic training program for 8 weeks.
    Wieczorek-Baranowska A; Nowak A; Pilaczyńska-Szcześniak Ł
    Metabolism; 2012 Apr; 61(4):542-5. PubMed ID: 22000586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of novel risk factors for postoperative severe hypocalcemia in patients with primary hyperparathyroidism undergoing parathyroidectomy: a case control study.
    Xu J; Kong N; Bai N; Zhang Z; Cui A; Tan S; Xu Q
    BMC Endocr Disord; 2024 Jun; 24(1):88. PubMed ID: 38867205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery.
    Kautzky-Willer A; Pacini G; Niederle B; Schernthaner G; Prager R
    Clin Endocrinol (Oxf); 1992 Aug; 37(2):147-55. PubMed ID: 1395065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary Hyperparathyroidism: The Influence of Bone Marrow Adipose Tissue on Bone Loss and of Osteocalcin on Insulin Resistance.
    Mendonça ML; Batista SL; Nogueira-Barbosa MH; Salmon CE; Paula FJ
    Clinics (Sao Paulo); 2016 Aug; 71(8):464-9. PubMed ID: 27626477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of urolithiasis before and after parathyroidectomy in patients with primary hyperparathyroidism.
    Elkoushy MA; Yu AX; Tabah R; Payne RJ; Dragomir A; Andonian S
    Urology; 2014 Jul; 84(1):22-6. PubMed ID: 24703459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations of total and undercarboxylated osteocalcin with peripheral and hepatic insulin sensitivity and β-cell function in overweight adults.
    Gower BA; Pollock NK; Casazza K; Clemens TL; Goree LL; Granger WM
    J Clin Endocrinol Metab; 2013 Jul; 98(7):E1173-80. PubMed ID: 23616149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rising Glucagon-Like Peptide 1 Concentrations After Parathyroidectomy in Patients With Primary Hyperparathyroidism.
    Antonopoulou V; Karras SN; Koufakis T; Yavropoulou M; Katsiki N; Gerou S; Papavramidis T; Kotsa K
    J Surg Res; 2020 Jan; 245():22-30. PubMed ID: 31400574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased markers of inflammation and endothelial dysfunction in patients with mild primary hyperparathyroidism.
    Almqvist EG; Bondeson AG; Bondeson L; Svensson J
    Scand J Clin Lab Invest; 2011 Apr; 71(2):139-44. PubMed ID: 21166606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin B6 status and interferon-γ-mediated immune activation in primary hyperparathyroidism.
    Christensen MH; Pedersen EK; Nordbø Y; Varhaug JE; Midttun Ø; Ueland PM; Nygård OK; Mellgren G; Lien EA
    J Intern Med; 2012 Dec; 272(6):583-91. PubMed ID: 22757621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.